Cooper Financial Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.99M | Buy |
8,265
+141
| +2% | +$48.3K | 0.25% | 71 |
|
|
2026
Q1 | $2.86M | Buy |
8,124
+485
| +6% | +$173K | 0.29% | 64 |
|
|
2025
Q4 | $2.5M | Sell |
7,639
-459
| -6% | -$146K | 0.27% | 66 |
|
|
2025
Q3 | $2.29M | Sell |
8,098
-160
| -2% | -$46.4K | 0.25% | 64 |
|
|
2025
Q2 | $2.31M | Sell |
8,258
-76
| -0.9% | -$21.5K | 0.27% | 65 |
|
|
2025
Q1 | $2.6M | Sell |
8,334
-10
| -0.1% | -$2.95K | 0.34% | 56 |
|
|
2024
Q4 | $2.17M | Buy |
8,344
+442
| +6% | +$131K | 0.26% | 65 |
|
|
2024
Q3 | $2.55M | Buy |
7,902
+216
| +3% | +$70.7K | 0.33% | 57 |
|
|
2024
Q2 | $2.4M | Sell |
7,686
-732
| -9% | -$215K | 0.35% | 52 |
|
|
2024
Q1 | $2.39M | Sell |
8,418
-60
| -0.7% | -$17.6K | 0.39% | 42 |
|
|
2023
Q4 | $2.44M | Buy |
8,478
+490
| +6% | +$134K | 0.44% | 39 |
|
|
2023
Q3 | $2.15M | Sell |
7,988
-68
| -0.8% | -$17K | 0.52% | 35 |
|
|
2023
Q2 | $1.79M | Sell |
8,056
-113
| -1% | -$26.2K | 0.44% | 48 |
|
|
2023
Q1 | $1.97M | Buy |
8,169
+362
| +5% | +$88.9K | 0.53% | 35 |
|
|
2022
Q4 | $2.05M | Buy |
7,807
+37
| +0.5% | +$9.92K | 0.63% | 33 |
|
|
2022
Q3 | $1.75M | Buy |
7,770
+139
| +2% | +$33.7K | 0.63% | 38 |
|
|
2022
Q2 | $1.86M | Sell |
7,631
-136
| -2% | -$33.3K | 0.67% | 36 |
|
|
2022
Q1 | $1.88M | Buy |
7,767
+180
| +2% | +$41.4K | 0.71% | 31 |
|
|
2021
Q4 | $1.71M | Sell |
7,587
-769
| -9% | -$162K | 0.64% | 35 |
|
|
2021
Q3 | $1.78M | Buy |
8,356
+202
| +2% | +$46.5K | 0.37% | 47 |
|
|
2021
Q2 | $1.99M | Buy |
8,154
+266
| +3% | +$65.4K | 0.4% | 39 |
|
|
2021
Q1 | $1.96M | Sell |
7,888
-1,052
| -12% | -$251K | 0.44% | 37 |
|
|
2020
Q4 | $2.06M | Buy |
8,940
+1,250
| +16% | +$288K | 0.42% | 39 |
|
|
2020
Q3 | $1.95M | Sell |
7,690
-301
| -4% | -$74.6K | 0.56% | 33 |
|
|
2020
Q2 | $1.89M | Buy |
7,991
+2,383
| +42% | +$544K | 0.61% | 30 |
|
|
2020
Q1 | $1.14M | Buy |
5,608
+453
| +9% | +$98.9K | 0.47% | 36 |
|
|
2019
Q4 | $1.24M | Sell |
5,155
-92
| -2% | -$20.3K | 0.5% | 27 |
|
|
2019
Q3 | $1.01M | Buy |
5,247
+1,003
| +24% | +$193K | 0.46% | 35 |
|
|
2019
Q2 | $782K | Buy |
4,244
+925
| +28% | +$166K | 0.38% | 39 |
|
|
2019
Q1 | $631K | Sell |
3,319
-757
| -19% | -$145K | 0.35% | 38 |
|
|
2018
Q4 | $794K | Buy |
+4,076
| New | +$795K | 0.54% | 27 |
|
Other funds holding AMGN
Cooper Financial Group's AMGN Position: Q2 2026 in Review
Cooper Financial Group increased its Amgen (AMGN) stake by 1.7% in Q2 2026, buying an estimated $48.3K and bringing the position to 8,265 shares worth $2.99M. The position accounts for 0.25% of the portfolio, ranked #71.
Cooper Financial Group first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cooper Financial Group held 8,265 shares of Amgen worth $2.99M as of Q2 2026.
- Cooper Financial Group bought 141 Amgen shares in Q2 2026, an estimated $48.3K.
- Amgen made up 0.25% of Cooper Financial Group's portfolio in Q2 2026, its #71 holding.
- Cooper Financial Group first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.